Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced receipt of its pain relief device prototype and provided an update on its TherOZap technology. Following introduction of the first design of its device for relief of general, arthritic or orthopedic pain in October, the company has rapidly advanced its development, received the prototype and identified a research group on which it will initiate efficacy tests. Therma Bright has also sent final prototypes of its TherOZap technology to a top research laboratory for testing of the technology against the Zika virus. “We are excited to announce these updates and will report the results of both technologies as they become available,” Therma Bright CEO Rob Fia stated in the news release. “As we diligently work to advance our technologies, our goal remains on strengthening our portfolio and pursuing new applications and opportunities.”
To view the full press release, visit http://cnw.fm/4IIy4
About Therma Bright Inc.
Therma Bright is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of the company’s philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The company’s breakthrough proprietary technology delivers effective, non-invasive and pain free skin care. For more information, visit the company’s website at www.ThermaBright.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com